Belizatinib T4257
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Belizatinib is an effective, oral and dual inhibitor of ALK (IC50: 0.7_nM, wild-type recombinant ALK) and TRKA, TRKB, and TRKC.
CAS nr:
1357920-84-3
Purity:
98%
Molecular Weight:
577,75
SMILES:
CC(C)NC(=O)[C@H]1CC[C@H](CC1)n1c(NC(=O)c2ccc(F)cc2)nc2ccc(CN3CCC(CC3)C(C)(C)O)cc12
Formula:
C33H44FN5O3
Pathway:
Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors
Target:
ALK,ALK,Trk receptor
